APPROVAL PROCESS IS INITIATED
ARE READY & SECURED BY PATENTS
OUR NEW DRUG FOR THERAPY IS READY.
the health of those we serve.
- IT´S OUR DAILY CHALLENGE
It´s their goal realizing best medical solutions.
IS IN PROGRESS FOR APPROVAL
ARE READY & SECURED BY PATENTS
Pharmact
OUR MISSION
At Pharmact, our mission is to improve the health of those we serve. We have focused on the most important clinical pictures, arteriosclerosis and diabetes.
.
Pharmact
INTERNATIONAL
We work worldwide with pharmaceutical wholeseller and distributions. We are pleased if you would like being part of our network.
.
Pharmact
MEDICAL DEVICES
Our IVD rapid test products are excellent for the screening of metabolic diseases and risk diagnosis. Take advantage of our Smart Devices.
.
NEWS PRODUCTS
Screening for metabolic diseases on early stages
The effective therapy of diabetes mellitus and arteriosclerosis as well as their sequelae is one of the greatest medical challenges of our time. More…
NEW PROJECTS
New substance in registration process
Arteriosclerosis is a silent disease that partially leads to calcifying hardening of the arterial system. Pharmact has developed a specific drug that is available from the beginning of Q2. 2020. The substance has now been entered the drug approval process.
Interested in more?
Ask our partners!
DISTRIBUTION
EUROPE
Pharmact GmbH
Int´l Distribution
Headquarters
Phone: +49 621-1806178-0
E-Mail: sales@pharmact.de
USA
Pharmact Healthcare Inc.
Distribution
USA / CAN
Phone: +1 813 200 5884
E-Mail:
sales@pharmact-us.com